Overview

Study of Sunobinop on Craving in Alcohol Use Disorder

Status:
COMPLETED
Trial end date:
2025-07-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol craving in subjects with moderate to severe alcohol use disorder and these subjects are seeking treatment.
Phase:
PHASE2
Details
Lead Sponsor:
Imbrium Therapeutics
Collaborator:
Purdue Pharma LP